Pay in 4 interest-free payments of $5.22 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
The combination of ursolic acid and sorafenib inhibits SLC7A11 and reduces GSH synthesis, while significantly increasing lipid peroxidation levels, inducing ferroptosis in cells, and reversing drug resistance in liver cancer cells, thereby exhibiting significant antitumor activity and providing a new therapeutic strategy for tumor treatment
4 Must-Have Eye Treatments for Unparalleled Results Skincare is personal and when it comes to caring for the skin around your eyes, its even more so
Frequently Asked Questions About NAD+ and Pain What is NAD+ used for in pain management
Discovery of direct inhibitors of Keap1-Nrf2 protein-protein interaction as potential therapeutic and preventive agents
US$ 29.03
US$ 22.68
US$ 20.40
US$ 29.17
US$ 29.31
US$ 27.31
US$ 23.60
